1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Oestrogens And Progestogens Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, 2022 & 2032F |
3.3 United Kingdom (UK) Oestrogens And Progestogens Market - Industry Life Cycle |
3.4 United Kingdom (UK) Oestrogens And Progestogens Market - Porter's Five Forces |
3.5 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 United Kingdom (UK) Oestrogens And Progestogens Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hormone replacement therapy (HRT) among women in the UK |
4.2.2 Rising prevalence of menopausal symptoms driving demand for oestrogens and progestogens |
4.2.3 Advancements in drug delivery technologies leading to improved efficacy and convenience of HRT products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of hormone therapy products in the UK |
4.3.2 Concerns regarding the potential side effects and risks associated with long-term use of oestrogens and progestogens |
5 United Kingdom (UK) Oestrogens And Progestogens Market Trends |
6 United Kingdom (UK) Oestrogens And Progestogens Market, By Types |
6.1 United Kingdom (UK) Oestrogens And Progestogens Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, By Aglepristone, 2022-2032F |
6.1.4 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, By Mifepristone, 2022-2032F |
6.1.5 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, By Asoprisnil, 2022-2032F |
6.1.6 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, By Telapristone, 2022-2032F |
6.1.7 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, By Ulipristal Acetate, 2022-2032F |
6.2 United Kingdom (UK) Oestrogens And Progestogens Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, By Pharmacy, 2022-2032F |
6.2.3 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, By Hospital, 2022-2032F |
6.2.4 United Kingdom (UK) Oestrogens And Progestogens Market Revenues & Volume, By Department Of Endocrinology, 2022-2032F |
7 United Kingdom (UK) Oestrogens And Progestogens Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Oestrogens And Progestogens Market Export to Major Countries |
7.2 United Kingdom (UK) Oestrogens And Progestogens Market Imports from Major Countries |
8 United Kingdom (UK) Oestrogens And Progestogens Market Key Performance Indicators |
8.1 Average age of women starting HRT in the UK |
8.2 Number of prescriptions for oestrogens and progestogens in the UK |
8.3 Percentage of women experiencing menopausal symptoms opting for HRT as a treatment option |
9 United Kingdom (UK) Oestrogens And Progestogens Market - Opportunity Assessment |
9.1 United Kingdom (UK) Oestrogens And Progestogens Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 United Kingdom (UK) Oestrogens And Progestogens Market Opportunity Assessment, By Application, 2022 & 2032F |
10 United Kingdom (UK) Oestrogens And Progestogens Market - Competitive Landscape |
10.1 United Kingdom (UK) Oestrogens And Progestogens Market Revenue Share, By Companies, 2025 |
10.2 United Kingdom (UK) Oestrogens And Progestogens Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |